Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-01-12 | 2023-06-09 | 180878 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-04-27 | 2023-06-09 | 190671 |
PEDIATRIX DROPS | 80MG | DROPS | Resolved | 2022-09-07 | 2023-06-09 | 168719 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-09 | 176770 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173049 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184198 |
TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-09 | 190716 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190728 |
TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184183 |
TEVA-CODEINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190701 |
TEVA-CHLORPROMAZINE | 25.0MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190761 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |